Studying liver volume changes after radiation therapy
Part of Cancer, Digestive system clinical trials.
This study looks at how the liver changes in size after radiation therapy. It uses CT scans taken before and after treatment to measure these changes, which could help doctors better understand and manage side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You received radiation therapy that affected your liver, either as the main target (like for liver cancer or metastases) or because it was near the treatment area (like for lung, stomach, or abdominal cancers).
- You had CT scans of good quality both before and after the radiation therapy.
- Your radiation treatment plan data is available, including 3D dose information.
- You have follow-up records, including liver function tests and any side effects you had.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how changes in liver size affect the planning and delivery of radiation therapy for cancers in the upper abdomen, such as pancreatic, bile duct, or liver cancer. It aims to improve treatment accuracy.
This trial studies how radiation therapy (SBRT) affects a DNA fragment in the blood called ctDNA in people with liver cancer. By tracking ctDNA changes, doctors hope to better understand how well the treatment is working and possibly predict outcomes earlier.
This study compares a standard radiation dose plan versus a plan that adjusts the dose based on how the tumor responds to radiation-related measurements. It aims to improve how well stereotactic body radiation therapy (SBRT) treats liver cancer while keeping side effects manageable.
This study tests new blood tests and MRI scans to see how well your liver works during radiation therapy for liver cancer. It may help doctors better plan treatment and monitor your liver health.
This study checks whether a special “contrast” medicine used in liver cancer can be clearly seen on CT images while you receive radiation. The goal is to better track where the medicine is during treatment, which may improve how radiation is guided.
This study looks at how doctors can use imaging scans to predict how well immunotherapy will work for people with liver cancer that cannot be removed by surgery. Participants must have already received immunotherapy and have had baseline scans.
Hear when a new Intra-abdominal Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.